These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32203905)

  • 1. Spleen contributes to restraint stress induced hepatocellular carcinoma progression.
    Jiang W; Li Y; Wei W; Li JW; Li L; Zhang C; Zhang SQ; Kong GY; Li ZF
    Int Immunopharmacol; 2020 Jun; 83():106420. PubMed ID: 32203905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic restraint stress promotes hepatocellular carcinoma growth by mobilizing splenic myeloid cells through activating β-adrenergic signaling.
    Jiang W; Li Y; Li ZZ; Sun J; Li JW; Wei W; Li L; Zhang C; Huang C; Yang SY; Yang J; Kong GY; Li ZF
    Brain Behav Immun; 2019 Aug; 80():825-838. PubMed ID: 31125710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of the spleen and its significance in a murine H22 orthotopic hepatoma model.
    Li B; Zhang S; Huang N; Chen H; Wang P; Li J; Pu Y; Yang J; Li Z
    Exp Biol Med (Maywood); 2016 Apr; 241(8):863-72. PubMed ID: 26989085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells.
    Li T; Harada M; Tamada K; Abe K; Nomoto K
    Anticancer Res; 1997; 17(6D):4259-68. PubMed ID: 9494518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spleen contributes to chronic restraint stress-induced lung injury through splenic CD11b
    Li Y; Liu H; Zhao D; Zhang D
    Int Immunopharmacol; 2024 Jan; 126():111258. PubMed ID: 37992443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.
    Li H; Han Y; Guo Q; Zhang M; Cao X
    J Immunol; 2009 Jan; 182(1):240-9. PubMed ID: 19109155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic restraint stress promotes the mobilization and recruitment of myeloid-derived suppressor cells through β-adrenergic-activated CXCL5-CXCR2-Erk signaling cascades.
    Cao M; Huang W; Chen Y; Li G; Liu N; Wu Y; Wang G; Li Q; Kong D; Xue T; Yang N; Liu Y
    Int J Cancer; 2021 Jul; 149(2):460-472. PubMed ID: 33751565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spleen contributes to the increase in PMN-MDSCs in orthotopic H22 hepatoma mice.
    Li BH; Jiang W; Zhang S; Huang N; Sun J; Yang J; Li ZF
    Mol Immunol; 2020 Sep; 125():95-103. PubMed ID: 32659598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation.
    Kusmartsev SA; Li Y; Chen SH
    J Immunol; 2000 Jul; 165(2):779-85. PubMed ID: 10878351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repetitive restraint stress changes spleen immune cell subsets through glucocorticoid receptor or β-adrenergic receptor in a stage dependent manner.
    Li Y; Jiang W; Li ZZ; Zhang C; Huang C; Yang J; Kong GY; Li ZF
    Biochem Biophys Res Commun; 2018 Jan; 495(1):1108-1114. PubMed ID: 29175389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the clinical significance of lymphocyte subsets and myeloid suppressor cells in patients with renal carcinoma.
    Li Y; Wu Z; Ni C; Li Y; Wang P
    Discov Oncol; 2024 Sep; 15(1):512. PubMed ID: 39347882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of Infected Gr-1
    Abdissa K; Nerlich A; Beineke A; Ruangkiattikul N; Pawar V; Heise U; Janze N; Falk C; Bruder D; Schleicher U; Bogdan C; Weiss S; Goethe R
    Front Immunol; 2018; 9():2317. PubMed ID: 30386330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.
    Dolcetti L; Peranzoni E; Ugel S; Marigo I; Fernandez Gomez A; Mesa C; Geilich M; Winkels G; Traggiai E; Casati A; Grassi F; Bronte V
    Eur J Immunol; 2010 Jan; 40(1):22-35. PubMed ID: 19941314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes.
    Watanabe S; Deguchi K; Zheng R; Tamai H; Wang LX; Cohen PA; Shu S
    J Immunol; 2008 Sep; 181(5):3291-300. PubMed ID: 18714001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid-derived suppressor cells attenuate TH1 development through IL-6 production to promote tumor progression.
    Tsukamoto H; Nishikata R; Senju S; Nishimura Y
    Cancer Immunol Res; 2013 Jul; 1(1):64-76. PubMed ID: 24777249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
    Greifenberg V; Ribechini E; Rössner S; Lutz MB
    Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between cellular immune response and spleen weight in mice with hepatocellular carcinoma.
    Jiang W; Li Y; Zhang S; Kong G; Li Z
    Oncol Lett; 2021 Aug; 22(2):625. PubMed ID: 34267817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echinacea purpurea Protects Against Restraint Stress-Induced Immunosuppression in BALB/c Mice.
    Park S; Lee MS; Jung S; Lee S; Kwon O; Kreuter MH; Perrinjaquet-Moccetti T; Min B; Yun SH; Kim Y
    J Med Food; 2018 Mar; 21(3):261-268. PubMed ID: 29215298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of hepatocellular carcinoma growth via oral immune regulation towards tumor-associated antigens is associated with increased NKT and CD8+ lymphocytes.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Oncology; 2004; 66(4):323-30. PubMed ID: 15218301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide-induced myeloid-derived suppressor cell population is immunosuppressive but not identical to myeloid-derived suppressor cells induced by growing TC-1 tumors.
    Mikyšková R; Indrová M; Polláková V; Bieblová J; Símová J; Reiniš M
    J Immunother; 2012 Jun; 35(5):374-84. PubMed ID: 22576342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.